[Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]

Rev Clin Esp. 2011 Mar;211(3):147-55. doi: 10.1016/j.rce.2010.11.006. Epub 2011 Mar 3.

[Article in Spanish]

Authors

E Menéndez Torre¹, J Lafita Tejedor, S Artola Menéndez, J Millán Núñez-Cortés, A Alonso García, M Puig Domingo, J R García Solans, F Alvarez Guisasola, J García Alegría, J Mediavilla Bravo, C Miranda Fernández-Santos, R Romero González; Sociedad Española de Diabetes

Affiliation

¹ En representación del Grupo de Trabajo de Consensos y Guías Clínicas de Sociedad Española de Diabetes, España. edelmiro.menendez@sespa.princast.es

PMID: 21376312
DOI: 10.1016/j.rce.2010.11.006

No abstract available

Publication types

Consensus Development Conference
Practice Guideline

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology*
Drug Therapy, Combination
Glycated Hemoglobin / analysis
Humans
Hyperglycemia / diagnosis
Hyperglycemia / drug therapy*
Hyperglycemia / etiology*
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Metformin / therapeutic use

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
Insulin
hemoglobin A1c protein, human
Metformin